Showing results (101-110 of 153) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2025
TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast CancerRachel O Abelman, Bogang Wu, Haley Barnes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2024
Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent TreatmentAparna R Parikh, Bryant H Chee, Jill Tsai, et al.
Cancer Discovery|April 7, 2021
Clinical Acquired Resistance to KRAS<sup>G12C</sup> Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS-MAPK ReactivationNoritaka Tanaka, Jessica J Lin, Chendi Li, et al.
JAMA Network Open|November 17, 2023
Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI CancerJoy X Jarnagin, Anurag Saraf, Islam Baiev, et al.
Cancer Research Communications|January 30, 2026
Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint InhibitorsNussara Pakvisal, Leontios Pappas, Bennett A Caughey, et al.
NPJ Precision Oncology|August 18, 2020
Small cell transformation of <i>ROS1</i> fusion-positive lung cancer resistant to ROS1 inhibitionJessica J Lin, Adam Langenbucher, Pranav Gupta, et al.
Cancer Discovery|December 7, 2011
BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitorsAnthony C Faber, Ryan B Corcoran, Hiromichi Ebi, et al.
Cancer Discovery|December 9, 2015
Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal CancerMariangela Russo, Giulia Siravegna, Lawrence S Blaszkowsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2020
<i>BRAF</i>-Mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade with Dabrafenib, Trametinib, and Panitumumab in Patients with Colorectal CancerGary Middleton, Yiqun Yang, Catarina D Campbell, et al.
Cancer|November 10, 2020
Associations of baseline patient-reported outcomes with treatment outcomes in advanced gastrointestinal cancerEmily E van Seventer, Madeleine G Fish, Kathryn Fosbenner, et al.
Pageof 16